• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553660
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); No Consequences Or Impact To Patient (2199); No Code Available (3191)
Event Date 06/24/2020
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2020 that a hot axios stent was implanted in a transgastric position to treat an encapsulated walled-off necrosis (won) in the pancreas during a hot axios stent placement procedure performed on (b)(6) 2020.Reportedly, the patient's won contained 10% necrosis, and the patient underwent 6 necrosectomy procedures.According to the complainant, on (b)(6) 2020, the patient experienced a severe pancreatic cyst hemorrhage.Interventional radiology (ir) and endoscopic hemostasis were performed.The patient also received a blood transfusion.There is no information available if there was a was relationship between the stent and the bleeding.Reportedly, on (b)(6) 2020, the bleeding was resolved and the patient had recovered.On (b)(6) 2020, the stent removal procedure was performed and the stent was successfully removed.
 
Event Description
It was reported to boston scientific corporation on july 30, 2020 that a hot axios stent was implanted in a transgastric position to treat an encapsulated walled-off necrosis (won) in the pancreas during a hot axios stent placement procedure performed on (b)(6)2020.Reportedly, the patient's won contained 10% necrosis, and the patient underwent 6 necrosectomy procedures.According to the complainant, on (b)(6) 2020, the patient experienced a severe pancreatic cyst hemorrhage.Interventional radiology (ir) and endoscopic hemostasis were performed.The patient also received a blood transfusion.There is no information available if there was a was relationship between the stent and the bleeding.Reportedly, on (b)(6) 2020, the bleeding was resolved and the patient had recovered.On (b)(6) 2020, the stent removal procedure was performed and the stent was successfully removed.Additional information received on august 20, 2020.The complainant reported that the patient experienced a severe pancreatic cyst hemorrhage.Further information from the complainant confirmed that the bleeding occurred from the same pancreatic cysts that hot axios stent was placed, but the bleeding point was not close to axios stent.According to the physician, the bleeding was not related to the axios stent.
 
Manufacturer Narrative
Blocks b5, e1 (initial reporter title, initial reporter first name and initial reporter last name), e3 and h6 (patient codes) have been updated with additional information received on august 20, 2020.Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: conclusion code 4316 is being used in lieu of an appropriate code to capture the conclusion of device not returned.Block h10: the complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10430636
MDR Text Key203653011
Report Number3005099803-2020-03474
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729951179
UDI-Public08714729951179
Combination Product (y/n)N
PMA/PMN Number
K163272
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00553660
Device Catalogue Number5366
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/30/2020
Initial Date FDA Received08/20/2020
Supplement Dates Manufacturer Received08/20/2020
Supplement Dates FDA Received09/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient Weight63
-
-